Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

ClinicalTrials.gov ID: NCT04446299

Public ClinicalTrials.gov record NCT04446299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 28, 2026, 9:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Study identification

NCT ID
NCT04446299
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Braintree Laboratories
Industry
Enrollment
519 participants

Conditions and interventions

Conditions

Interventions

  • Bowel Prep Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 12, 2020
Primary completion
Dec 21, 2020
Completion
Jan 21, 2021
Last update posted
Nov 6, 2023

2020 – 2021

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
301 Research Site 18 Huntsville Alabama 38501
301 Research Site 24 Sun City Arizona 85351
301 Research Site 7 San Diego California 92114
301 Research Site 16 Clearwater Florida 33756
301 Research Site 12 Jacksonville Florida 32216
301 Research Site 9 Palm Harbor Florida 34684
301 Research Site 4 Palmetto Bay Florida 33157
301 Research Site 26 Port Orange Florida 32127
301 Research Site 14 St. Petersburg Florida 33709
301 Research Site 25 Sunrise Florida 33351
301 Research Site 2 Decatur Georgia 30033
301 Research Site 10 Indianapolis Indiana 46202
301 Research Site 3 Monroe Louisiana 71201
301 Research Site 17 Shreveport Louisiana 71105
301 Research Site 11 Flowood Mississippi 39232
301 Research Site 13 Chesterfield Missouri 48047
301 Research Site 19 Reno Nevada 89511
301 Research Site 15 Brooklyn New York 11235
301 Research Site 5 Great Neck New York 11023
301 Research Site 23 New York New York 10033
301 Research Site 6 Raleigh North Carolina 27612
301 Research Site 21 Mentor Ohio 44060
301 Research Site 20 Hixson Tennessee 37434
301 Research Site 1 Ogden Utah 84405
301 Research Site 22 Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04446299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2023 · Synced Jun 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04446299 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →